257 related articles for article (PubMed ID: 26073032)
1. Neurofibromatosis type 1 and malignancy in childhood.
Varan A; Şen H; Aydın B; Yalçın B; Kutluk T; Akyüz C
Clin Genet; 2016 Mar; 89(3):341-5. PubMed ID: 26073032
[TBL] [Abstract][Full Text] [Related]
2. Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1.
Ferrari A; Bisogno G; Macaluso A; Casanova M; D'Angelo P; Pierani P; Zanetti I; Alaggio R; Cecchetto G; Carli M
Cancer; 2007 Apr; 109(7):1406-12. PubMed ID: 17330850
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
Friedrich RE; Beer C; Glatzel M; Hagel C
Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
[TBL] [Abstract][Full Text] [Related]
4. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
5. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
[TBL] [Abstract][Full Text] [Related]
6. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.
Friedrich RE; Hartmann M; Mautner VF
Anticancer Res; 2007; 27(4A):1957-60. PubMed ID: 17649804
[TBL] [Abstract][Full Text] [Related]
7. Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.
Park SJ; Sawitzki B; Kluwe L; Mautner VF; Holtkamp N; Kurtz A
BMC Med; 2013 Apr; 11():109. PubMed ID: 23618374
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
[TBL] [Abstract][Full Text] [Related]
9. Examining perceived cancer risk among patients with neurofibromatosis type 1.
Park ER; Smith KB; Merker VL; Muzikansky A; Vranceanu AM; Wang DL; Plotkin SR
J Neurooncol; 2015 Mar; 122(1):127-33. PubMed ID: 25559686
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
[TBL] [Abstract][Full Text] [Related]
11. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.
Ferner RE; Gutmann DH
Cancer Res; 2002 Mar; 62(5):1573-7. PubMed ID: 11894862
[TBL] [Abstract][Full Text] [Related]
12. Pilomatrixoma of the Neck/Shoulder Region Mimicking a Rapidly Growing Neoplasm of Peripheral Nerve Sheath Origin in Neurofibromatosis Type 1.
Friedrich RE; Schüller U; Hagel C
Anticancer Res; 2017 Dec; 37(12):6907-6910. PubMed ID: 29187472
[TBL] [Abstract][Full Text] [Related]
13. Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1.
McCaughan JA; Holloway SM; Davidson R; Lam WW
J Med Genet; 2007 Jul; 44(7):463-6. PubMed ID: 17327286
[TBL] [Abstract][Full Text] [Related]
14. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals.
Mantripragada KK; Caley M; Stephens P; Jones CJ; Kluwe L; Guha A; Mautner V; Upadhyaya M
Genes Chromosomes Cancer; 2008 Mar; 47(3):238-46. PubMed ID: 18069666
[TBL] [Abstract][Full Text] [Related]
16. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
17. Giant malignant nerve sheath tumor of lumbosacral plexus with intraspinal extension in a child with neurofibromatosis type 1.
Pratap A; Nepal P; Agrawal A; Singh MP; Pandey SR
Pediatr Neurosurg; 2007; 43(5):410-3. PubMed ID: 17786009
[TBL] [Abstract][Full Text] [Related]
18. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.
Kamran SC; Howard SA; Shinagare AB; Krajewski KM; Jagannathan JP; Hornick JL; Ramaiya NH
Eur J Surg Oncol; 2013 Jan; 39(1):46-52. PubMed ID: 23084090
[TBL] [Abstract][Full Text] [Related]
19. Bilateral spinal neurofibromas in patients with neurofibromatosis 1.
Pascual-Castroviejo I; Pascual-Pascual SI; Viaño J; Velazquez-Fragua R; López-Gutierrez JC
Brain Dev; 2012 Aug; 34(7):563-9. PubMed ID: 21999966
[TBL] [Abstract][Full Text] [Related]
20. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
Ziadi A; Saliba I
Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]